JPH05507496A - 抗高コレステロール血ビス―トリフルオロメチル置換イミダゾリンおよびその誘導体 - Google Patents

抗高コレステロール血ビス―トリフルオロメチル置換イミダゾリンおよびその誘導体

Info

Publication number
JPH05507496A
JPH05507496A JP91512272A JP51227291A JPH05507496A JP H05507496 A JPH05507496 A JP H05507496A JP 91512272 A JP91512272 A JP 91512272A JP 51227291 A JP51227291 A JP 51227291A JP H05507496 A JPH05507496 A JP H05507496A
Authority
JP
Japan
Prior art keywords
effective amount
atherosclerosis
compound
acat
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP91512272A
Other languages
English (en)
Japanese (ja)
Inventor
ビルハイマー，ジエフリー・トマス
ボスウエル・ジユニア，ジヨージ・アルバート
デ・ルツカ，インダワテイ
ドラモンド・ジユニア，スペンサー
ギリーズ，ピーター・ジヨン
トジヤスコス，ジエイムズ・マイクル
Original Assignee
ザ・デュポン・メルク・ファーマシュウティカル・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・デュポン・メルク・ファーマシュウティカル・カンパニー filed Critical ザ・デュポン・メルク・ファーマシュウティカル・カンパニー
Publication of JPH05507496A publication Critical patent/JPH05507496A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP91512272A 1990-06-05 1991-05-31 抗高コレステロール血ビス―トリフルオロメチル置換イミダゾリンおよびその誘導体 Pending JPH05507496A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53356590A 1990-06-05 1990-06-05
US533,565 1990-06-05
PCT/US1991/003854 WO1991019476A1 (en) 1990-06-05 1991-05-31 Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof

Publications (1)

Publication Number Publication Date
JPH05507496A true JPH05507496A (ja) 1993-10-28

Family

ID=24126523

Family Applications (1)

Application Number Title Priority Date Filing Date
JP91512272A Pending JPH05507496A (ja) 1990-06-05 1991-05-31 抗高コレステロール血ビス―トリフルオロメチル置換イミダゾリンおよびその誘導体

Country Status (10)

Country Link
EP (1) EP0536316A4 (ko)
JP (1) JPH05507496A (ko)
KR (1) KR930700453A (ko)
AU (1) AU650026B2 (ko)
CA (1) CA2084399A1 (ko)
IE (1) IE911909A1 (ko)
IL (1) IL98342A0 (ko)
NZ (1) NZ238390A (ko)
WO (1) WO1991019476A1 (ko)
ZA (1) ZA914285B (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428948A (en) * 1977-02-03 1984-01-31 Rohm And Haas Company Novel heterocyclic compounds

Also Published As

Publication number Publication date
EP0536316A4 (en) 1993-11-18
AU650026B2 (en) 1994-06-09
CA2084399A1 (en) 1991-12-06
WO1991019476A1 (en) 1991-12-26
KR930700453A (ko) 1993-03-15
EP0536316A1 (en) 1993-04-14
ZA914285B (en) 1993-02-24
AU8194391A (en) 1992-01-07
IE911909A1 (en) 1991-12-18
IL98342A0 (en) 1992-07-15
NZ238390A (en) 1994-04-27

Similar Documents

Publication Publication Date Title
RU2451015C2 (ru) Производные 1,2,4-триазола в качестве ингибиторов сигма рецептора
RU2197477C2 (ru) Производные адамантана, способ их получения, фармацевтическая композиция на их основе, способ ее получения и способ воздействия на иммуносупрессию
US4089962A (en) Acylamino triazoles as antiasthmatic agents
HU184966B (en) Process for producing phenyl-piperazine derivatives of anti-agression activity
FR2501690A1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
CS216544B2 (en) Method of preparation of basic ethers
US6215001B1 (en) Imidazole derivatives as therapeutic agents
JP2008526815A (ja) 低コンダクタンスのカルシウム依存性カリウムチャネルのモジュレーターとしての新規２−アミノベンゾイミダゾール誘導体及びそれらの使用
JPH0764813B2 (ja) 新規化合物および医薬組成物
NL8000333A (nl) Imidazoolderivaten, alsmede farmaceutische preparaten die dergelijke derivaten bevatten en werkwijze voor de bereiding van deze derivaten.
TW318830B (ko)
EP0677042B1 (fr) Ligands selectifs des recepteurs 5ht1d-5ht1b derives d'indole-piperazine utiles comme medicaments
JPH01313467A (ja) 置換１―（１ｈ―イミダゾール―４―イル）アルキル―ベンズアミド
JP2008509111A (ja) ２−アミノベンズイミダゾール誘導体及び小コンダクタンスカルシウム依存性カリウムチャネルのモジュレーターとしてのその使用
EP0482183B1 (fr) Composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation
US5547972A (en) Therapeutic agents useful for treating inflammatory diseases
IE52630B1 (en) Substituted biphenyl compounds
JPH02258756A (ja) 抗高脂肪血性および抗アテローム動脈硬化性のトリ置換尿素化合物
JPS58113140A (ja) ナフトキシアルキル化合物、その製造法およびそれからなる抗炎症剤
JPH05507496A (ja) 抗高コレステロール血ビス―トリフルオロメチル置換イミダゾリンおよびその誘導体
US5420348A (en) Urea derivatives and salts thereof
FI85139B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara indolkarboxamidderivat samt deras salter.
US5428041A (en) Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof
JP2967231B2 (ja) １，４―チアジン誘導体
PL91401B1 (ko)